NEOGENOMICS, INC. (NEO) FY2026 Q2 Balance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
NEOGENOMICS, INC. (NEO) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$105.88 MLiabilities$566.51 MCurrent assets$381.48 MAssets$1.35 BNon-current liabilities$460.63 MNon-current assets$970.77 MEquity$785.73 MGross equity(calculated)$1.26 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netCash and cash equivalentsInventoriesPrepaid assetsOther current assetsGoodwillIntangible assets, netProperty and equipment (net of accumulated depreciation of $223,479 and $209,057, respectively)Operating lease right-of-use assetsOther assetsFinancing lease right-of-use assetsAccrued compensationAccrued expenses and other liabilitiesAccounts payableCurrent portion of operating lease liabilitiesCurrent portion of finance lease liabilitiesContract liabilitiesConvertible senior notes, net (Note 6)Operating lease liabilitiesDeferred income tax liabilities, netFinance lease liabilitiesOther long-term liabilitiesAdditional paid-in capitalCommon stock, $0.001 par value, (250,000,000 shares authorized; 130,301,168 and 128,989,152 shares issued, respectively; 127,917,946 and 128,989,152 shares outstanding, respectively)Accumulated other comprehensive incomeCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitTreasury stock, at cost, (2,383,222 and 0 shares, respectively) (Note 7)Accrued compensationAccrued compensation$56.27 MAccrued expenses and other liabilitiesAccrued expenses and other liabilities$23.05 MCurrent liabilitiesCurrent liabilities$105.88 MAccounts payableAccounts payable$20.95 MCurrent portion of operating lease liabilitiesCurrent portion of operating lease liabilities$3.72 MAccounts receivable, netAccounts receivable, net$175.41 MLiabilitiesLiabilities$566.51 MCurrent portion of finance lease liabilitiesCurrent portion of finance lease liabilities$1.70 MCurrent assetsCurrent assets$381.48 MCash and cash equivalentsCash and cash equivalents$145.54 MContract liabilitiesContract liabilities$194.00 KInventoriesInventories$27.14 MAssetsAssets$1.35 BConvertible senior notes, net (Note 6)Convertible senior notes, net (Note 6)$374.24 MNon-current liabilitiesNon-current liabilities$460.63 MPrepaid assetsPrepaid assets$23.59 MOther current assetsOther current assets$9.81 MOperating lease liabilitiesOperating lease liabilities$64.67 MDeferred income tax liabilities, netDeferred income tax liabilities, net$16.82 MNon-current assetsNon-current assets$970.77 MGoodwillGoodwill$524.00 MEquityEquity$785.73 MFinance lease liabilitiesFinance lease liabilities$4.03 MOther long-term liabilitiesOther long-term liabilities$862.00 KGross equity (calculated)Gross equity(calculated)$1.26 BIntangible assets, netIntangible assets, net$271.26 MProperty and equipment (net of accumulated depreciation of $223,479 and $209,057, respectively)Property and equipment$80.94 MOperating lease right-of-use assetsOperating lease right-of-use assets$78.61 MAdditional paid-in capitalAdditional paid-in capital$1.26 BOther assetsOther assets$9.31 MFinancing lease right-of-use assetsFinancing lease right-of-use assets$6.65 MCommon stock, $0.001 par value, (250,000,000 shares authorized; 130,301,168 and 128,989,152 shares issued, respectively; 127,917,946 and 128,989,152 shares outstanding, respectively)Common stock$130.00 KAccumulated other comprehensive incomeAccumulated other comprehensive income$4.00 KAccumulated deficitAccumulated deficit−$448.67 MTreasury stock, at cost, (2,383,222 and 0 shares, respectively) (Note 7)Treasury stock−$25.00 M
Chart details

NEOGENOMICS, INC. (NEO) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
1,352,243,000 US dollars
Current assets
381,478,000 US dollars
Non-current assets
970,765,000 US dollars
Liabilities
566,511,000 US dollars
Current liabilities
105,883,000 US dollars
Non-current liabilities
460,628,000 US dollars
Equity
785,732,000 US dollars
Accounts receivable, net
175,405,000 US dollars
Cash and cash equivalents
145,539,000 US dollars
Inventories
27,137,000 US dollars
Prepaid assets
23,590,000 US dollars
Other current assets
9,807,000 US dollars
Goodwill
523,995,000 US dollars
Intangible assets, net
271,262,000 US dollars
Property and equipment (net of accumulated depreciation of $223,479 and $209,057, respectively)
80,938,000 US dollars
Operating lease right-of-use assets
78,606,000 US dollars
Other assets
9,311,000 US dollars
Financing lease right-of-use assets
6,653,000 US dollars
Accrued compensation
56,265,000 US dollars
Accrued expenses and other liabilities
23,045,000 US dollars
Accounts payable
20,953,000 US dollars
Current portion of operating lease liabilities
3,722,000 US dollars
Current portion of finance lease liabilities
1,704,000 US dollars
Contract liabilities
194,000 US dollars
Convertible senior notes, net (Note 6)
374,241,000 US dollars
Operating lease liabilities
64,671,000 US dollars
Deferred income tax liabilities, net
16,824,000 US dollars
Finance lease liabilities
4,030,000 US dollars
Other long-term liabilities
862,000 US dollars
Additional paid-in capital
1,259,272,000 US dollars
Common stock, $0.001 par value, (250,000,000 shares authorized; 130,301,168 and 128,989,152 shares issued, respectively; 127,917,946 and 128,989,152 shares outstanding, respectively)
130,000 US dollars
Accumulated other comprehensive income
4,000 US dollars
Accumulated deficit
negative 448,674,000 US dollars
Treasury stock, at cost, (2,383,222 and 0 shares, respectively) (Note 7)
negative 25,000,000 US dollars
Gross equity (calculated)
1,259,406,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
NEOGENOMICS, INC. (NEO) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!